Iliad Partners

Iliad Partners is a Dubai-based venture firm with a regional thesis built around the Middle East and North Africa technology ecosystem, and its healthcare exposure tends to focus on health IT software and tech-enabled care delivery rather than consumer or therapeutic plays. The firm writes $1M-$5M checks at seed and Series A and operates as one of the more institutional early-stage names in a region that is increasingly producing serious technology companies.

The declared sub-verticals are health IT software and care delivery and tech-enabled services, with an AI lens. In practice that means interest in clinical workflow software, healthcare data infrastructure, telehealth and hybrid care models built for regional patient populations, and AI applications inside healthcare enterprises across the Gulf and the broader MENA region. The firm is less active in therapeutics, in hardware-only diagnostics, or in pure consumer wellness without operational depth. The strongest fits are companies addressing the structural undersupply of healthcare technology in MENA markets and building toward defensible enterprise positions.

Check sizes of $1M-$5M place Iliad as a credible lead or co-lead on early-stage rounds in the region, often anchoring the syndicate that subsequent international or regional investors join. Geographically the focus is MENA, with particular density in the Gulf Cooperation Council countries and selective interest in companies expanding into the region from adjacent markets. The firm has cultivated relationships with regional family offices, sovereign-aligned investors, and global funds that participate in MENA growth rounds, and that network is part of what founders are accepting when they take a check.

The team is built around investors and operators with deep regional experience and global fund backgrounds. Diligence tends to be substantive and relationship-oriented, with sharp attention to the regional dynamics that drive healthcare buying decisions, including the role of government health authorities, large hospital groups, and insurance regulators in different countries. Founders should expect detailed conversations about the path from early product to enterprise contracts in MENA-specific buyer environments.

For founders, the practical read is that Iliad is a credible early-stage partner for healthcare IT and tech-enabled services companies operating in MENA, particularly those scaling from a Gulf base into the broader region. It is less useful for US-only companies, for therapeutics, or for founders who want a generalist tech investor without regional context. The engagement style is hands-on and regionally informed, with real time spent on go-to-market, government and enterprise relationships, and follow-on fundraising. Founders building healthcare technology in MENA and looking for an institutional early-stage partner with serious regional depth will find this firm one of the more credible options in Dubai’s growing venture ecosystem.